Clinical Trials List
Protocol NumberD1680C00003
Not yet recruiting
2010-08-01 - 2016-01-31
Phase III
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Kang-Ling Wang Division of Cardiovascular Diseases
- 陳隆景 醫師 Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
- 黃柏勳 醫師 Division of Cardiovascular Diseases
- Wen-Chung Yu Division of Cardiovascular Diseases
- 潘如濱 醫師 Division of Cardiovascular Diseases
- 黃金洲 醫師 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
200 participants
-
Global
12840 participants